Software-designed miniproteins could create new class of drugs.
Where this comes from
- Record sourced from PubMed, PMID 35357932.
- Also identified by DOI 10.1126/science.abq2804.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Small versions of antibodies bind to virtually any target protein.
Medical subject headings
- Antibodies
- Drug Design
- Software